Blockchain in Healthcare Market Quantitative Analysis, Current and Future Trends

1. Healthcare © P&S Intelligence. All rights reserved Page 1

2. Why are Healthcare Organizations Adopting Blockchain Solutions? As per a P&S Intelligence report, the global blockchain in healthcare market is predicted to reach a value of $890.5 million by 2023, from $44.6 million in 2017, and is expected to advance at a 67.1% CAGR during the forecast period (2018–2023). The market is growing due to the increasing investments and funding in the blockchain technology, rising number of regulations for safeguarding consumer data, and implementation of blockchain in pharmaceutical supply chain. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market- analysis/blockchain-in-healthcare-market/report-sample On the basis of application, the market is divided into prescription drug abuse, drug discovery and clinical trials, drug supply chain management, claims adjunction and billing management, clinical data exchange and interoperability, and others. Out of these, the clinical data exchange and interoperability application held the major share of 40.0% of the market in 2017, due to the fact that the blockchain technology can transform the way clinical information and data are stored and shared across the total care continuum, such as patients, payers, and healthcare partners. Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry- url=blockchain-in-healthcare-market Geographically, the blockchain in healthcare market was dominated by North America in 2017, however, the European region is projected to emerge as the largest market by 2023. The major reasons for this is the implementation of various blockchain initiatives by private and public sector players in the region. The Asia-Pacific region is expected to progress at the fastest pace during the forecast period, which can be ascribed to the increasing focus on the blockchain technology in the region for catering to the unmet needs in areas of drug supply chain management and clinical data exchange and interoperability. The blockchain technology is still in the nascent stage, owing to which companies that are interested in adopting the technology are collaborating and partnering with several technology providers for exploring its potential applications. For example, a deal between NMC Health, a United Arab Emirates (UAE) based private sector healthcare provider, and Guardtime AS, an Estonian blockchain pioneer, was finalized in January 2018 for introducing the technology in the country. In conclusion, the market is being driven by the rising implementation of regulations for safeguarding consumer data and rising number of collaborations and partnerships. © P&S Intelligence. All rights reserved Page 2

3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved Page 3